Generation of Multilayered 3D Structures of HepG2 Cells Using a Bio-printing Technique
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND/AIMS: Chronic liver disease is a major widespread cause of death, and whole liver transplantation is the only definitive treatment for patients with end-stage liver diseases. However, many problems, including donor shortage, surgical complications and cost, hinder their usage. Recently, tissue-engineering technology provided a potential breakthrough for solving these problems. Three-dimensional (3D) printing technology has been used to mimic tissues and organs suitable for transplantation, but applications for the liver have been rare. METHODS: A 3D bioprinting system was used to construct 3D printed hepatic structures using alginate. HepG2 cells were cultured on these 3D structures for 3 weeks and examined by fluorescence microscopy, histology and immunohistochemistry. The expression of liverspecific markers was quantified on days 1, 7, 14, and 21. RESULTS: The cells grew well on the alginate scaffold, and liver-specific gene expression increased. The cells grew more extensively in 3D culture than two-dimensional culture and exhibited better structural aspects of the liver, indicating that the 3D bioprinting method recapitulates the liver architecture. CONCLUSIONS: The 3D bioprinting of hepatic structures appears feasible. This technology may become a major tool and provide a bridge between basic science and the clinical challenges for regenerative medicine of the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“This factor has contributed to the poor predictive power of preclinical cell-based drug and toxicity screening assays.(22,29,30) Furthermore, most candidate drugs passing through in vitro preclinical trials have failed to meet the desired efficacy or safety margins prior to entering subsequent clinical trials, perhaps…”
BackgroundOn the mechanisms of biocompatibility
Williams, D. F. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.023 · Cited by 2,772
Recent advances in 3D printing of biomaterials
Chia, H. N., & Wu, B. M. (2015) · Journal of Biological Engineering · doi:10.1186/s13036-015-0001-4 · Cited by 1,734
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · cited 1×
“However, although PSC-derived hepatocyte-like cells have representative features of primary hepatocytes, repopulation capacity in vivo, as well as restoration of the liver function,(9-11) most researchers are aware of the inherent limitations of cells grown under twodimensional (2D) conditions.(12-14) In general, tiss…”
BackgroundInduction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X., & Hui, L. (2011) · Nature · doi:10.1038/nature10116 · Cited by 864 · cited 3×
“mouse liver failure model are capable of repopulating the liver and restores normal liver structure without fusion with recipient cells.(24-27) For many years, 2D culture systems have been widely used in biological research and drug screening.”
BackgroundDirect conversion of mouse fibroblasts to hepatocyte-like cells by defined factors
Sekiya, S., & Suzuki, A. (2011) · Nature · doi:10.1038/nature10263 · Cited by 846
Generation of Functional Human Hepatic Endoderm From Human Induced Pluripotent Stem Cells
Sullivan, G. J., Hay, D. C., Park, I.-H., Fletcher, J., Hannoun, Z., Payne, C. M., Dalgetty, D., Black, J. R., Ross, J. A., Samuel, K., et al. (2010) · Hepatology · doi:10.1002/hep.23335 · Cited by 445 · cited 2×
“To obtain a number of hepatocytes, direct differentiation technology using pluripotent stem cells (PSCs) has been developed.(1-4) Since PSCs can replicate themselves infinitely and differentiate into most of cell types including hepatocytes, they are considered as an alternative cell source for supplying unlimited num…”
BackgroundDifferentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro
Baharvand, H., Hashemi, S. M., Kazemi Ashtiani, S., & Farrokhi, A. (2006) · The International Journal of Developmental Biology · doi:10.1387/ijdb.052072hb · Cited by 429
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming
Du, Y., Wang, J., Jia, J., Song, N., Xiang, C., Xu, J., Hou, Z., Su, X., Liu, B., Jiang, T., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.008 · Cited by 320 · cited 4×
“Moreover, they are able to repopulate after transplantation in vivo and restore the liver functions.(5,7-11,24) Although the strategies for obtaining pure and high quality of hepatocyte-like cells from PSCs have been improved, however, it cannot be perfectly ruled out the risk of oncogenicity originated from residuall…”
BackgroundInfluential
Research works printed but not linked: 25
- 10.1634/stemcells.2007-1102 · DOI · Paper page
- 10.1016/j.jhep.2010.06.014 · DOI
- 10.1111/j.1365-2443.2008.01201.x · DOI · Paper page
- 10.1053/j.gastro.2008.10.047 · DOI · Paper page
- 10.1634/stemcells.2007-0291 · DOI · Paper page
- 10.1016/j.diff.2010.01.002 · DOI
- 10.1002/hep.23506 · DOI · Paper page
- 10.1016/j.biocel.2012.01.002 · DOI
- 10.1038/nbt1257 · DOI · Paper page
- 10.1002/hep.20629 · DOI · Paper page
- 10.1371/journal.pone.0086372 · DOI · Paper page
- 10.1016/S0167-7799(03)00033-7 · DOI · Paper page
- 10.1016/S0959-440X(98)80039-0 · DOI
- 10.1038/35041030 · DOI · Paper page
- 10.1038/nchem.1313 · DOI · Paper page
- 10.1038/487022a · DOI · Paper page
- 10.1038/nbt.2958 · DOI · Paper page
- 10.1007/s10545-006-0245-8 · DOI · Paper page
- 10.1016/j.stem.2014.01.003 · DOI · Paper page
- 10.1002/ar.a.10059 · DOI · Paper page
- 10.1016/j.jbiotec.2010.02.001 · DOI
- 10.1002/jbm.a.34420 · DOI · Paper page
- 10.1088/1758-5082/2/2/022001 · DOI · Paper page
- 10.1088/1758-5082/4/2/022001 · DOI · Paper page
- 10.3350/cmh.2015.21.1.7 · DOI
Cited by
3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances
Derakhshanfar, S., Mbeleck, R., Xu, K., Zhang, X., Zhong, W., & Xing, M. (2018) · Bioactive Materials · doi:10.1016/j.bioactmat.2017.11.008 · Cited by 1,027
Biofabrication strategies for 3D in vitro models and regenerative medicine
Moroni, L., Burdick, J. A., Highley, C., Lee, S. J., Morimoto, Y., Takeuchi, S., & Yoo, J. J. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0006-y · Cited by 753
Self-citationThe Role of 3D Printing in Medical Applications: A State of the Art
Aimar, A., Palermo, A., & Innocenti, B. (2019) · Journal of Healthcare Engineering · doi:10.1155/2019/5340616 · Cited by 685
Alginate and alginate composites for biomedical applications
Ahmad Raus, R., Wan Nawawi, W. M. F., & Nasaruddin, R. R. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.10.001 · Cited by 627
Review of alginate-based hydrogel bioprinting for application in tissue engineering
Rastogi, P., & Kandasubramanian, B. (2019) · Biofabrication · doi:10.1088/1758-5090/ab331e · Cited by 564
Metadata
- Authors
- Jeon, H., Kang, K., Park, S. A., Kim, W. D., Paik, S. S., Lee, S.-H., Jeong, J., & Choi, D.
- Venue
- Gut and Liver
- Published
- 2017-01-15
- Volume
- 11
- Issue
- 1
- Pages
- 121-128
- ISSN
- 1976-2283 (ISSN-L)
- 2005-1212
- OpenAlex
- W2514830645
- Cited by
- 110
- References
- 9
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- diamond
- Licence
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- Funders
- Hanyang University(HYU) (HY-2014)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.